CRM
TMO icon

Cramer Rosenthal McGlynn’s Thermo Fisher Scientific TMO Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-66,200
Closed -$8.29M – 244
2014
Q4 		$8.29M Buy
+66,200
New +$8.05M 0.09% 164

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Cramer Rosenthal McGlynn's TMO Position: Q1 2015 in Review

Cramer Rosenthal McGlynn sold out of Thermo Fisher Scientific (TMO) in Q1 2015, closing a stake of 66,200 shares — an estimated $8.29M sold.

Cramer Rosenthal McGlynn first reported a position in TMO in Q4 2014 and held it in 1 quarter. The position peaked at $8.29M in Q4 2014. 964 funds tracked by Wall St. Rank hold TMO as of Q1 2015.

  • Cramer Rosenthal McGlynn reported no remaining Thermo Fisher Scientific position as of Q1 2015 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 66,200 Thermo Fisher Scientific shares in Q1 2015, an estimated $8.29M.
  • Cramer Rosenthal McGlynn first reported a position in Thermo Fisher Scientific in Q4 2014 and held it in 1 quarter.
  • Cramer Rosenthal McGlynn's Thermo Fisher Scientific position peaked at $8.29M in Q4 2014.
  • 964 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2015.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2015, filed 15 May 2015.